title: [Empiric antituberculous therapy in patients with unexplained exsudative pleural effusion. Is it valid in Senegal?].
abstract: OBJECTIVE
  Pleural biopsy and adenosine deaminase activity are not available at our center and the treatment begins without substantiation diagnosis in patients with tuberculous pleural effusion (PE).
  
  
  METHODS
  In order to evaluate the validity of an empiric antituberculous therapy in exsudative PE with high prevalence of lymphocytes, we conducted a retrospective study during 1 year. Patient was enrolled if no signs of tuberculous infection, pneumonia or cancer were present.
  
  
  RESULTS
  During 1 year, 38 patients were enrolled (23 males, mean age=36 years). PE was major (> 2/3 of the lung) in 14 cases, moderate (between 1/3 and 2/3) In 18 cases and minor (<1/3) in 6 cases. Tuberculous contagion was observed in 10 patients. Tuberculinic test was positive in all patients (12-24 mm). Clinical and radiological cure was obtained in 37 cases, except 1 patient who died from acute heart failure. No recurrence of PE was observed after 1 year follow-up.
  
  
  CONCLUSIONS
  In our endemic areas, empiric antituberculous treatment seems to be an effective strategy in patients with exsudative PE.
authors.affiliation: Services médicaux, Hôpital Principal, Dakar, Sénégal.
authors.forename: M
authors.initials: M
authors.lastname: Sané
authors.forename: K
authors.initials: K
authors.lastname: Ba-Fall
authors.forename: N
authors.initials: N
authors.lastname: Lefebvre
authors.forename: D
authors.initials: D
authors.lastname: Mounguengui
authors.forename: P
authors.initials: P
authors.lastname: Camara
authors.forename: A
authors.initials: A
authors.lastname: Niang
authors.forename: A
authors.initials: A
authors.lastname: Bonnichon
authors.forename: B
authors.initials: B
authors.lastname: Chevalier
authors.forename: P
authors.initials: P
authors.lastname: Saliou-Mbaye
authors.forename: J-M
authors.initials: JM
authors.lastname: Debonne
authors.forename: J
authors.initials: J
authors.lastname: Margery
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002423:Cause of Death; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000503:physiopathology; D006801:Humans; D008218:Lymphocytosis / Q000473:pathology; D008297:Male; D010996:Pleural Effusion / Q000188:drug therapy* / Q000473:pathology; D012189:Retrospective Studies; D012675:Senegal; D016896:Treatment Outcome; D014374:Tuberculin Test; D014396:Tuberculosis, Pleural / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents